Objective: tumor. Strategies of drug targeting at the tumor mass level

Area of Science:

• Oncology
• Drug Delivery Systems
• Nanomedicine

Background:

• Ongoing development of novel anticancer drugs necessitates strategies to improve existing therapies.
• Key research areas include reducing drug toxicity, enhancing administration, and overcoming drug resistance.
• Drug targeting systems offer a unified approach to address these critical challenges in cancer treatment.

Purpose of the Study:

• To review strategies and systems for optimizing the efficacy of established anticancer agents.
• To discuss how drug targeting enhances therapeutic outcomes by improving drug concentration at tumor sites.
• To analyze the features of various drug targeting systems concerning toxicity, efficacy, and administration.

Main Methods:

• Review of literature on drug targeting systems in cancer therapy.
• Discussion of polymeric-drug conjugates, polymeric micelles, liposomes, albumin conjugates, and nanoparticles.
• Analysis of the characteristics of these systems related to toxicity, efficacy, and administration.

Main Results:

• Drug targeting systems enable localized drug delivery to tumor masses, increasing efficacy and reducing systemic toxicity.
• Sustained drug concentration at the tumor site optimizes therapeutic action.
• Various strategies like polymeric conjugates, micelles, liposomes, and nanoparticles demonstrate potential for improved cancer treatment.

Conclusions:

• Drug targeting systems are crucial for enhancing the efficacy of existing anticancer drugs.
• These systems effectively reduce toxicity and improve drug administration by concentrating agents at tumor sites.
• Further research into nanoparticle-based and other advanced drug delivery systems holds significant promise for improving cancer patient outcomes.